5. The Management of Growth Disorders
Published Online: 23 FEB 2012
DOI: 10.1002/9781119968153.ch5
Copyright © 2012 John Wiley & Sons, Ltd.
Book Title

Handbook of Clinical Pediatric Endocrinology, Second Edition
Additional Information
How to Cite
Brook, C. G. D. and Dattani, M. T. (2012) The Management of Growth Disorders, in Handbook of Clinical Pediatric Endocrinology, Second Edition, Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781119968153.ch5
Publication History
- Published Online: 23 FEB 2012
- Published Print: 13 APR 2012
ISBN Information
Print ISBN: 9780470657881
Online ISBN: 9781119968153
- Summary
- Chapter
Keywords:
- body measurement;
- dysmorphic syndromes;
- growth;
- growth assessment;
- growth hormone (GH);
- height velocity;
- insulin-like growth factor (IGF)-1;
- Prader–Willi syndrome;
- psychosocial short stature;
- sex steroids;
- short stature;
- skeletal dysplasias;
- tall stature;
- thyroxine;
- Turner syndrome
Summary
All endocrine orders affect growth. This chapter describes how to measure growth and how to detect and treat growth disorders. Postnatal growth is characterized by an infancy phase, regulated by nutrition, a childhood phase regulated by growth hormone and thyroxine and puberty growth regulated by sex steroids. Since normal growth is defined by a normal growth rate, regardless of height achieved, an understanding of how such rates vary in the three phases is key to determining further investigation. Since treatment follows diagnosis, nutrition, growth hormone and sex steroids all have parts to play. Growth hormone is also used in other situations which the chapter describes. A new area of clinical practice is the poor growth which follows the treatment of cancer. Tall stature can be a serious long-term problem as short stature is usually a short-term one; it is extremely important to rule out a diagnosis of precocious puberty and thyrotoxicosis, as well as gigantism.
